EcoDrugPlus

Sodium Channel Protein Type 4 Subunit Alpha B

Ensembl ID : ENSELUG00000018230
Gene Symbol: LOC105030614
3 Cross references
263 Possible Orthologues:

Sodium Channel Protein Type 8 Subunit Alpha

Ensembl ID : ENSELUG00000010904
Gene Symbol: LOC105023837
2 Cross references
218 Possible Orthologues:

Sodium Channel, Voltage Gated, Type Xii, Alpha A

Ensembl ID : ENSELUG00000015580
Gene Symbol: SCN12AA
1 Cross references
245 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 8

Ensembl ID : ENSELUG00000019010
Gene Symbol: SCN8A
1 Cross references
219 Possible Orthologues:

Sodium- And Chloride-Dependent Gaba Transporter 1

Ensembl ID : ENSELUG00000016865
Gene Symbol: LOC105029134
3 Cross references
204 Possible Orthologues:

Sodium/glucose Cotransporter 1

Ensembl ID : ENSELUG00000018612
Gene Symbol: LOC105014972
3 Cross references
250 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Alpha-2

Ensembl ID : ENSELUG00000001123
Gene Symbol: LOC105024552
3 Cross references
206 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2

Ensembl ID : ENSELUG00000006552
Gene Symbol: LOC105023914
3 Cross references
197 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-2-Like

Ensembl ID : ENSELUG00000028936
Gene Symbol: LOC105008587
3 Cross references
192 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-233-Like

Ensembl ID : ENSELUG00000001828
Gene Symbol: LOC105019706
3 Cross references
170 Possible Orthologues:

Sodium/potassium-Transporting Atpase Subunit Beta-3

Ensembl ID : ENSELUG00000017090
Gene Symbol: LOC105026800
3 Cross references
230 Possible Orthologues:

Solute Carrier Family 10 Member 2

Ensembl ID : ENSELUG00000014451
Gene Symbol: SLC10A2
3 Cross references
210 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).